The Federal Government recently proposed changes to private health insurance, which is expected to result in up to $1 billion of claims savings over the first four years of operation. This is mainly through a reduction in prices paid for medical devices and prosthesis. The measures are designed to simplify and homogenise the products across providers. It will also allow discounts for customers aged under 30 in order to encourage them into private health insurance. The discounts are 2% for …

Read MoreProposed changes to Private Health Insurance: Impact on NIB

What are bonds? When you purchase shares, you are essential purchasing a part ownership in a company. Bonds on the other hand are debt obligations. A buyer of a bond is a lender, they are lending their money to a company or government in exchange for interest payments. A buyer of a $1,000 bond with a coupon of 5 percent paying semi-annually with a maturity of 10 years will receive $25 (2.5% *$1000) twice a year for the next 10 …

Read MoreThe relationship between bonds, interest rates, and stocks

After reporting well in August, Mirvac (MGR) is now trading near multi-year highs. Do the fundamentals stack up at these pricing levels, and what are the charts suggesting for an entry level? The fundamental viewpoint Mirvac’s EPS growth guidance of 6-8% for FY18 implies another year of strong EPS growth. While there are market concerns around a weaker level of EPS growth in FY19, driven by weaker Residential divisional earnings (as apartment volumes declines are skewed to Brisbane and Perth …

Read MoreDetermining an investment opportunity with Mirvac

Sentiment towards Santos has improved a great deal recently. The company has reduced costs and the price of oil seems to have stabilised for now. The interim update in August even managed to beat expectations. We looked at Santos a couple of times in the last few months, noting the bullish nature of the chart. The rally in the last few weeks further confirms our view. It now becomes clear that the stock has much more upside from here and …

Read MoreGet ready to buy the dip in Santos

Xero (XRO) is a chart that we have followed a few times this year and the stock continues to climb. Price action is once again indicating that there from current levels, we should expect even more upside for Xero. It first came to our attention in April when it finally broke through resistance in the mid $19’s. This breakout was on high volume. This means that the stock was likely to go on a run. And go for a run …

Read MoreXero is about to rally even higher